NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features (Q44257677)

1 December 2017

NPM1 mutations in therapy-related acute myeloid leukemia with uncharacteristic features (English)

1 reference

therapy-related acute myeloid leukemia

1 December 2017

0 references

1 reference

M T Andersen

1

1 reference

1 December 2017

M K Andersen

series ordinal

2

1 reference

1 December 2017

D H Christiansen

series ordinal

3

1 reference

1 December 2017

J Pedersen-Bjergaard

series ordinal

4

1 reference

1 December 2017

14 February 2008

1 reference

1 December 2017

1 reference

1 December 2017

22

1 reference

1 December 2017

951-955

1 reference

1 December 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.17

1 December 2017

0 references

cites work

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Major nucleolar proteins shuttle between nucleus and cytoplasm

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

The ribonuclease activity of nucleolar protein B23.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Preferential cleavage in pre-ribosomal RNA byprotein B23 endoribonuclease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleophosmin is essential for ribosomal protein L5 nuclear export

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleophosmin is required for DNA integrity and p19Arf protein stability

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Role of nucleophosmin in embryonic development and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Nucleophosmin regulates the stability and transcriptional activity of p53

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Cooperativity between mutations in tyrosine kinases and in hematopoietic transcription factors in AML.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Genetics of myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Mutations of the PTPN11 gene in therapy-related MDS and AML with rare balanced chromosome translocations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Any role for the nucleophosmin (NPM1) gene in myelodysplastic syndromes and acute myeloid leukemia with chromosome 5 abnormalities?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Risk of leukemia after chemotherapy and radiation treatment for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Genetics of therapy-related myelodysplasia and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.17

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.17

1 reference

1 December 2017

1 reference